CMAB Biopharma (Suzhou) Inc., a dedicated biologics contract manufacturing and development organization (CDMO), has appointed Maggie Chen as chief financial officer. Chen will lay a solid foundation for the long-term development of CDMO business and commences a new milestone for CMAB.   Experience   Chen has nearly 20 years of experience in listing, merger and acquisition, group comprehensive financial management and capital operation. In her career, she has served several pharmaceutical and bio...